In March 2025, the company introduced new plans for the immediate-to-client providing of its Wegovy weight loss drug. The company set up a whole new pharmacy, known as NovoCare, which would demand prospects $499 per month for access to the drug, less than 50 % the expense of the drug by way of other pharmaceutical distribution networks.[fifty three